169 related articles for article (PubMed ID: 20688625)
61. Repeated remissions of Cushing's disease due to recurrent infarctions of an ACTH-producing pituitary macroadenoma.
Alarifi A; Alzahrani AS; Salam SA; Ahmed M; Kanaan I
Pituitary; 2005; 8(2):81-7. PubMed ID: 16195779
[TBL] [Abstract][Full Text] [Related]
62. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
63. Pituitary-directed medical therapy in Cushing's disease.
Petersenn S; Fleseriu M
Pituitary; 2015 Apr; 18(2):238-44. PubMed ID: 25627118
[TBL] [Abstract][Full Text] [Related]
64. Radiation optic neuropathy after external beam radiation therapy for acromegaly: report of two cases.
van den Bergh AC; Hoving MA; Links TP; Dullaart RP; Ranchor AV; ter Weeme CA; Canrinus AA; Szabó BG; Pott JW
Radiother Oncol; 2003 Aug; 68(2):101-3. PubMed ID: 12972303
[TBL] [Abstract][Full Text] [Related]
65. Radiation necrosis of the optic chiasm, optic tract, hypothalamus, and upper pons after radiotherapy for pituitary adenoma, detected by gadolinium-enhanced, T1-weighted magnetic resonance imaging: case report.
Tachibana O; Yamaguchi N; Yamashima T; Yamashita J
Neurosurgery; 1990 Oct; 27(4):640-3. PubMed ID: 2234373
[TBL] [Abstract][Full Text] [Related]
66. Approach to the postoperative patient with Cushing's disease.
Rutkowski MJ; Breshears JD; Kunwar S; Aghi MK; Blevins LS
Pituitary; 2015 Apr; 18(2):232-7. PubMed ID: 25702104
[TBL] [Abstract][Full Text] [Related]
67. Current status on histological classification in Cushing's disease.
Syro LV; Rotondo F; Cusimano MD; Di Ieva A; Horvath E; Restrepo LM; Wong M; Killinger DW; Smyth H; Kovacs K
Pituitary; 2015 Apr; 18(2):217-24. PubMed ID: 25501318
[TBL] [Abstract][Full Text] [Related]
68. Somatostatin and somatostatin receptors in Cushing's disease.
Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
[TBL] [Abstract][Full Text] [Related]
69. Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma.
Miyoshi T; Otsuka F; Takeda M; Inagaki K; Suzuki J; Ogura T; Date I; Hashimoto K; Makino H
J Endocrinol Invest; 2004 Dec; 27(11):1055-9. PubMed ID: 15754738
[TBL] [Abstract][Full Text] [Related]
70. Desmopressin test in the diagnosis and follow-up of cyclical Cushing's disease.
Leal-Cerro A; Martín-Rodríguez JF; Ibáñez-Costa A; Madrazo-Atutxa A; Venegas-Moreno E; León-Justel A; García-Hernández N; Luque RM; Castaño JP; Cano DA; Soto-Moreno A
Endocrinol Nutr; 2014 Feb; 61(2):69-76. PubMed ID: 24183946
[TBL] [Abstract][Full Text] [Related]
71. Cushing's syndrome: comparison between Cushing's disease and adrenal Cushing's.
Hirsch D; Shimon I; Manisterski Y; Aviran-Barak N; Amitai O; Nadler V; Alboim S; Kopel V; Tsvetov G
Endocrine; 2018 Dec; 62(3):712-720. PubMed ID: 30084101
[TBL] [Abstract][Full Text] [Related]
72. Radiation-induced optic neuropathy.
Flickinger JC
J Neurosurg; 1991 Sep; 75(3):496-7. PubMed ID: 1741842
[No Abstract] [Full Text] [Related]
73. Objective evaluation of improvement in optic neuropathy following radiation therapy for thyroid eye disease.
Rush S; Winterkorn JM; Zak R
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):191-4. PubMed ID: 10758323
[TBL] [Abstract][Full Text] [Related]
74. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.
Prevedello DM; Pouratian N; Sherman J; Jane JA; Vance ML; Lopes MB; Laws ER
J Neurosurg; 2008 Oct; 109(4):751-9. PubMed ID: 18826366
[TBL] [Abstract][Full Text] [Related]
75. Applications of radiotherapy and radiosurgery in the management of pediatric Cushing's disease: a review of the literature and our experience.
Jagannathan J; Kanter AS; Olson C; Sherman JH; Laws ER; Sheehan JP
J Neurooncol; 2008 Oct; 90(1):117-24. PubMed ID: 18568291
[TBL] [Abstract][Full Text] [Related]
76. Clinical significance of screening for subclinical Cushing's disease in patients with pituitary tumors.
Tamada D; Kitamura T; Otsuki M; Oshino S; Saitoh Y; Shimomura I
Endocr J; 2016; 63(1):47-52. PubMed ID: 26536898
[TBL] [Abstract][Full Text] [Related]
77. Pituicytoma and Cushing's Disease in a 7-Year-Old Girl: A Mere Coincidence?
Cambiaso P; Amodio D; Procaccini E; Longo D; Galassi S; Camassei FD; Cappa M
Pediatrics; 2015 Dec; 136(6):e1632-6. PubMed ID: 26553184
[TBL] [Abstract][Full Text] [Related]
78. Assessment of the outcomes of the treatment of Cushing's disease in the hospitals of Castilla-La Mancha.
Huguet I; Aguirre M; Vicente A; Alramadan M; Quiroga I; Silva J; Lamas C
Endocrinol Nutr; 2015 May; 62(5):217-23. PubMed ID: 25842035
[TBL] [Abstract][Full Text] [Related]
79. Optic chiasm enhancement associated with giant aneurysm and yttrium treated pituitary adenoma.
Gabriel CM; Stevens JC; Bremner F; Brew S; Plant GT
J Neurol Neurosurg Psychiatry; 2004 Sep; 75(9):1343-5. PubMed ID: 15314130
[TBL] [Abstract][Full Text] [Related]
80. Optic nerve sheath fenestration for a reversible optic neuropathy in radiation oncology.
Mohamed IG; Roa W; Fulton D; Halls S; Jha N; Kherani A; Johnson R
Am J Clin Oncol; 2000 Aug; 23(4):401-5. PubMed ID: 10955872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
